Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Breast Neoplasms 15Neoplasms 4Neoplasm Metastasis 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Breast Diseases 2Tuberous Sclerosis 1Thoracic Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Obesity 1Neuroendocrine Tumors 1Neoplasms by Site 1Lymphoma 1Lung Neoplasms 1Lung Diseases 1Kidney Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Carcinoma, Bronchogenic 1Bronchial Neoplasms 1Breast Neoplasms, Male 1Acrocephalosyndactylia 1

Interventions

Metformin 2rosiglitazone-metformin combination 1mirabegron 1exemestane 1atezolizumab 1Tirzepatide 1TIC10 compound 1Rosiglitazone 1Hydroquinones 1Fish Oils 1Docosahexaenoic Acids 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Obesity × exemestane × Clear all
NCT00933309 2016-02-19

The Impact of Obesity and Obesity Treatments on Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
25 enrolled
BreastOther

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡